Autopsy report · NCT02231853
Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections
Cause of deathNo reason given
Life of this trial
- Ran for about 3 years 4 months before it stopped.
- 12 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Chronic Lymphocytic Leukemia; CML (Chronic Myelogenous Leukemia); MDS (Myelodysplastic Syndrome); Acute Lymphoblastic Leukemia; AML (Acute Myelogenous Leukemia)
- Interventions
- MVST; MVSTr
- Participants
- 12
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.